Establishment and characterization of a mantle cell lymphoma cell line

Area of Science:

• Hematology
• Oncology
• Cell Biology

Background:

• Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin B-cell lymphoma.
• Establishing reliable cell lines is crucial for understanding MCL pathogenesis and developing therapies.
• The leukaemic large cell variant of MCL presents unique clinical and biological characteristics.

Observation:

• A novel MCL cell line, designated JeKo-1, was derived from the peripheral blood of a patient with leukaemic large cell MCL.
• JeKo-1 cells demonstrated a B-cell phenotype (IgM+, IgD+, CD5+, CD19+, CD20+) and were Epstein-Barr virus negative.
• These cells exhibited overexpression of key regulatory proteins including cyclin D1, Bcl-2, c-Myc, and Rb.

Findings:

• Polymerase chain reaction confirmed the characteristic Bcl-1/J(H) gene rearrangement, a hallmark of MCL.
• Karyotypic analysis revealed chromosomal abnormalities but lacked the typical t(11;14) translocation.
• JeKo-1 cells proved to be highly tumorigenic when xenografted into SCID mice.

Implications:

• The JeKo-1 cell line serves as a valuable in vitro and in vivo model for studying MCL, particularly the leukaemic large cell variant.
• This model can facilitate research into the molecular mechanisms driving MCL progression and drug resistance.
• Further characterization may reveal unique therapeutic vulnerabilities associated with this specific MCL subtype.